Home » Clients and cases

Clients and cases

Clients

Clients and cases

Medical device, healthcare and industrial companies we have supported, directly or with our partner in Beijing, and examples of recent projects.

Medical devices and healthcare

Other industries and universities

Partners

Our partner Best-Road (Beijing) works with us on NMPA clinical evaluation and regulatory advice.

Case studies

Five recent projects, described without naming the clients. Select a case to read the full story.

Case 1Translating a 33,000-paragraph DICOM Conformance Statement for NMPA registrationA European ophthalmic imaging device manufacturer preparing an NMPA registration dossier.

The challenge

The dossier needed a Chinese version of the device’s DICOM Conformance Statement: about 33,900 paragraphs and 150 tables of attribute definitions, coded terms and module listings.

Why a standard approach was not enough

Most of the text repeats the same structures thousands of times, mixed with DICOM tags, value representations and defined terms that must not be translated. Segment-by-segment translation produces inconsistent wording across entries and risks translating codes that the software reads.

What we did

We set rules for what stays in English (tags, value representations, defined terms) and what is translated (descriptions and code meanings). Recurring sentence structures were translated once and applied consistently. Terminology was aligned with the device’s other registration documents, and every table, field and cross-reference was checked against the source after translation.

What we delivered

The complete Chinese DICOM Conformance Statement in the original layout, and a bilingual XLIFF file for the client’s translation memory.

The result

The client’s validation comments were worked through over several review rounds, and the document went into the registration dossier.

Case 2Literature reviews to guide R&D decisions for two neurovascular devicesThe China clinical research team of a global neurovascular device company.

The challenge

The team needed an evidence-based view of where a liquid embolic agent and a balloon guide catheter stood against the field, and which development directions the evidence supported.

Why a standard approach was not enough

Product and competitor information was scattered across journals, registries and Chinese-language sources. A narrative summary would not tell management which gaps were real or which options were worth funding.

What we did

We ran systematic searches in PubMed, Embase and Wanfang, screened against predefined criteria, and extracted outcomes into an evidence pool. We built a state-of-the-art benchmark by dimension, placed each product and its competitors against it, and turned the gaps into ranked development candidates.

What we delivered

Two review reports analysing 163 and 171 references, each with a decision-oriented executive summary, an EndNote library and a working Excel evidence pool.

The result

The client described the work as “a clear, evidence-based picture of the field, and a strategy we could take to management with confidence.” It led to a follow-on five-year clinical research strategy plan across the company’s four product lines, prepared for presentation to the global team.

Case 3A representativeness argument for an NMPA indication expansionA registrant of a cardiovascular surgical repair device already approved in China, working with our partner Best-Road (Beijing).

The challenge

The client applied to extend the approved anatomical scope to further regions of the same organ, with no change to the device. NMPA asked for evidence that the approved indication was representative of the new sites.

Why a standard approach was not enough

The data existed. The difficulty was the argument: listing diseases, procedures and references for each site does not show the reviewer why existing clinical data cover the new indications.

What we did

We built a three-part argument. Completeness mapped each new site to its diseases, procedures and guidelines. Representativeness set the most demanding mechanical condition of the approved indication as the upper bound and showed, by anatomy, haemodynamics and surgical technique, that the new sites fall within it. Quantification used engineering models and the material test data to calculate safety factors at each site.

What we delivered

A deficiency response with the full chain of reasoning, supporting literature and calculations.

The result

The response was accepted by NMPA.

Case 4Bilingual design control documents for a new pen needleA global diabetes care company developing a new pen needle for the Chinese market.

The challenge

The design and development plan, design validation plan and design traceability matrix had to be available in English and Chinese in a single controlled document, with the client’s validated terminology.

Why a standard approach was not enough

A separate Chinese translation would split the controlled record into two documents that could drift apart. The traceability matrix, a 76-row by 12-column table, also had to stay exactly aligned with the English requirements.

What we did

We produced each document in bilingual format, English followed by Chinese in the same paragraph and cell, without changing numbering, fields, figures or page structure. The client’s glossary was applied throughout, and terminology corrections from the client’s validation round were carried across all three documents.

What we delivered

Three bilingual controlled documents and matching XLIFF files.

The result

The documents passed the client’s validation review and are maintained as bilingual records.

Case 5Software description documents in the NMPA template structureA European hearing implant manufacturer preparing NMPA registration documents.

The challenge

The software description documents had been written for other markets and had to be presented in the structure of the NMPA template, in Chinese.

Why a standard approach was not enough

A direct translation keeps the source structure, which does not match what Chinese reviewers expect. Electrical safety terms also had to follow the Chinese national standard rather than a general translation.

What we did

We translated the documents into the NMPA template structure and aligned electrical safety terminology with GB 9706.1. Cross-references and bookmarked fields were protected so that internal references still worked in the Chinese version.

What we delivered

Chinese software description documents in the NMPA structure, with terminology consistent with the rest of the dossier.

The result

The documents were submitted to NMPA as part of the registration dossier.

What clients say

“We greatly appreciate the excellent quality of the translation.”

GE HealthCare, October 2023

“BBM’s clinical literature evaluation was thorough and well organised. Every conclusion could be traced back to its source, which made our submission work much easier.”

Best-Road (Beijing), 2025

“The literature review gave our team a clear, evidence-based picture of the field, and a strategy we could take to management with confidence.”

TNC, 2026

Have documents to translate, or need dossier preparation for NMPA submission?

Send us what you have and your deadline. We will reply with a quote.

Request a quote

Auckland, New Zealand

Mobile: +64 21 0265 2722

vincent_yu@bbm.co.nz

WeChat: vincentyu2014

Partner in Beijing

Beijing BBM Translation Service Co., Ltd.

3rd Floor, China Minerals Tower, Beijing 100101

Phone: +86 10 8483 3996

bbm@bbmbj.com

WeChat: shelly-0818

Brisbane, Australia

Client contact point

Mobile: +61 406 844 857

vincent_yu@bbm.co.nz

© 2026 BBM. BBM is a trading name of Auckland BBM Translation Service Limited.

Privacy Policy

Powered by WordPress / Academica WordPress Theme by WPZOOM